Malignant neoplasm of glottis
ICD-10 C32.0 is a billable code used to indicate a diagnosis of malignant neoplasm of glottis.
Malignant neoplasm of the glottis refers to cancerous growths that occur in the vocal cords, which are located in the larynx. This type of cancer is often associated with risk factors such as tobacco use, excessive alcohol consumption, and exposure to certain chemicals. Symptoms may include hoarseness, difficulty swallowing, and persistent cough. Diagnosis typically involves laryngoscopy and biopsy to confirm malignancy. Treatment options vary based on the stage of cancer and may include surgery, radiation therapy, and chemotherapy. Voice preservation is a critical consideration in treatment planning, especially for patients who rely on their voice for professional or personal reasons. Staging of laryngeal cancer is crucial for determining the extent of disease and guiding treatment decisions. The TNM classification system is commonly used, where 'T' indicates the size and extent of the primary tumor, 'N' indicates regional lymph node involvement, and 'M' indicates the presence of metastasis. Early detection and appropriate management are essential for improving outcomes in patients with glottic cancer.
Detailed descriptions of tumor size, location, and staging; treatment plans; and follow-up care.
Patients presenting with hoarseness, difficulty breathing, or swallowing; post-operative follow-ups after laryngeal surgery.
Documentation must clearly indicate the intent of treatment and any voice preservation techniques employed.
Comprehensive treatment plans, including chemotherapy and radiation details, and response to treatment.
Management of advanced laryngeal cancer, including palliative care considerations.
Coordination with other specialties for comprehensive care and accurate coding of multi-disciplinary treatment approaches.
Used for initial evaluation of suspected glottic cancer.
Document findings from the laryngoscopy and any biopsies performed.
Otolaryngologists must ensure thorough documentation of the procedure and findings.
Performed for treatment of glottic cancer with voice preservation.
Detailed operative report including extent of resection and voice preservation techniques.
Oncologists should coordinate with surgeons for accurate coding of the procedure.
Common symptoms include hoarseness, difficulty swallowing, throat pain, and persistent cough. Patients may also experience changes in voice quality.
Glottic cancer is staged using the TNM classification system, which assesses tumor size (T), lymph node involvement (N), and metastasis (M).
Treatment options may include surgery, radiation therapy, and chemotherapy, with a focus on voice preservation when possible.
Documentation should include tumor size, location, staging, treatment intent, and any co-existing conditions that may affect management.
